Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06458049 · ClinicalTrials.gov registry record · NA

Sexual Health and Rehabilitation Online (SHAREonline)

A NA study of Cancer Survivorship and Sexual Function Disturbances, sponsored by Dana-Farber Cancer Institute.

Active
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT06458049 is a NA study of Cancer Survivorship and Sexual Function Disturbances that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 84 participants, below the 253-participant average among 11 other Cancer Survivorship trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06458049, a NA study of Cancer Survivorship and Sexual Function Disturbances, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

SHAREonline is a study for young female cancer survivors that are experiencing changes in sexual health and function. The purpose of this research is to compare two brief interventions delivered by videoconference to learn if they help women effectively manage these changes and restore sexual health and functioning.

Interventions

  • BEHAVIORAL Educational Materials
  • BEHAVIORAL Group Session
  • BEHAVIORAL Coaching Call

Study Locations (1)

Massachusetts

  • Dana Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2025-02-19
Est. Completion 2027-05-31
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT06458049

The ClinicalTrials.gov registry entry for NCT06458049 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 253-participant average among 11 other Cancer Survivorship trials with a reported enrollment target (67% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer Survivorship appearing as the primary indexed condition, and to 3 interventions - of which Educational Materials is the first listed.

NCT06458049 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06458049 about?

NCT06458049 is a clinical study titled "Sexual Health and Rehabilitation Online (SHAREonline)". SHAREonline is a study for young female cancer survivors that are experiencing changes in sexual health and function. The purpose of this research is to compare two brief interventions delivered by videoconference to learn if they help women effectively manage these changes and restore sexual healt...

What is the current status of trial NCT06458049?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2025-02-19. Estimated completion is 2027-05-31.

What conditions does trial NCT06458049 study?

This clinical trial studies the following conditions: Cancer Survivorship, Sexual Function Disturbances.

What interventions are being tested in trial NCT06458049?

The interventions under investigation include: Educational Materials (BEHAVIORAL), Group Session (BEHAVIORAL), Coaching Call (BEHAVIORAL).

Who is sponsoring clinical trial NCT06458049?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06458049 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Survivorship

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.